Canadian Consortium on Neurodegeneration in Aging (CCNA)

Google Translate Limitations Disclaimer

The electronic translation service on the brainXchange website is hosted by Google Translate, an external translation service. The brainXchange does not guarantee or warrant the reliability, accuracy or completeness of any translated information. The basic translation goal is to capture the general information of the original English website content. If any questions arise related to the accuracy of the information contained in the translated website, please refer to the English version of the website.

Now Featuring

Differentiating apathy from depression in neurocognitive disorders: case presentation and discussion (slides) Presenters: Dr. Krista L. Lanctôt, PhD, Bernick Chair in Geriatric Psychopharmacology; Senior Scientist, Sunnybrook Research Institute; Professor of Psychiatry and Pharmacology, Vice Chair, Basic and Clinical Sciences, Department of Psychiatry, University of Toronto; Dr. Damien Gallagher MB, MD, MRCPsych, FRCPC, Geriatric Psychiatrist, Sunnybrook Health Sciences Centre; Dr. Damien Gallagher MB, MD, MRCPsych, FRCPC; Dr. Giovanni Marotta, MD, FRCP(c); Geriatrician, Internist, Sunnybrook Health Sciences Centre

A Framework for Remote Cognitive Diagnostic Assessment and Digital Biomarkers in Dementia (slides), Dr. Maiya Geddes, MD, FRCPC

What You Need to Know and Do About Vascular Health and Its Link to Brain Health (slides) Presenter: Dr. Eric Smith, MD, MPH, FRCPC, FAHABrain Health PRO

Brain Health PRO, Canadian Consortium of Neurodegeneration in Aging (CCNA)

Sensory & Cognitive Health (slides), Presenters: Kathy Pichora-Fuller, PhD, Professor Emerita, University of Toronto, and Walter Wittich, PhD, FAAO, CLVT, Associate Professor, School of Optometry, University of Montreal

Resources

Sex and Gender Hub, Canadian Consortium on Neurodegeneration in Aging (CCNA) - The goal of the Sex and Gender Hub is to bring the sex and gender lens into dementia research in Canada. The aim is to enable CCNA’s research teams to capture important sex and gender differences in the prevalence, incidence, symptoms, progression, and treatment of neurodegenerative diseases.